Surviving Benzodiazepines: A Patient's and Clinician's Perspectives. 2022

Carrie M Silvernail, and Steven L Wright
Alliance for Benzodiazepine Best Practices, 3221 NE 30th Ave, Portland, OR, 97212, USA.

Although benzodiazepines have been used for 6 decades, many questions remain unanswered by research. The lived experiences of those adversely affected long term can provide insights into how these agents might be more thoughtfully prescribed. Here, perspectives of one such experience encompassing benzodiazepine initiation, ongoing use with adverse consequences and difficult discontinuation are presented through the eyes of an affected individual and a clinician. This experience highlights the importance of limited initiation and duration of use (2-4 weeks) as well as a supported, slow tapering process led by patients. Because researched evidence about deprescribing benzodiazepines is insufficient and because individual experiences vary so widely, it is the patient's expertise-that of her or his lived experience-that should assume a primary role in determining the course and pace of discontinuing these medications.

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

Carrie M Silvernail, and Steven L Wright
October 2018, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Carrie M Silvernail, and Steven L Wright
January 1992, Clinical neuropharmacology,
Carrie M Silvernail, and Steven L Wright
May 2006, BMJ (Clinical research ed.),
Carrie M Silvernail, and Steven L Wright
January 2012, Jornal da Sociedade Brasileira de Fonoaudiologia,
Carrie M Silvernail, and Steven L Wright
January 1963, Proceedings of the Royal Society of Medicine,
Carrie M Silvernail, and Steven L Wright
October 2009, International archives of medicine,
Carrie M Silvernail, and Steven L Wright
September 2018, Critical care nursing clinics of North America,
Carrie M Silvernail, and Steven L Wright
January 1988, Birth defects original article series,
Carrie M Silvernail, and Steven L Wright
January 1983, Journal of psychoactive drugs,
Carrie M Silvernail, and Steven L Wright
May 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Copied contents to your clipboard!